DiscoverIP Protection Matters“Most Favored Nation” Drug Pricing’s Impact on IP and Innovation
“Most Favored Nation” Drug Pricing’s Impact on IP and Innovation

“Most Favored Nation” Drug Pricing’s Impact on IP and Innovation

Update: 2025-12-08
Share

Description

Grover Norquist, President of Americans for Tax Reform, explains how “Most Favored Nation” drug pricing is effectively the importing of counterproductive foreign nation price controls, how the policy would raise the cost of new inventions, and how increased fees and/or taxes on patents run counter to the Trump administration’s pro-growth agenda.
Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

“Most Favored Nation” Drug Pricing’s Impact on IP and Innovation

“Most Favored Nation” Drug Pricing’s Impact on IP and Innovation

IP Protection Matters